Ophthalmology is one of medicine's most specialized fields. Its trials demand precision, subspecialty knowledge, and teams who truly understand the pathophysiology, the endpoints, and the regulatory landscape.
aCROss Vision was built for exactly that.
As a dedicated division of aCROss Medical, we bring deep, hands-on experience across ophthalmology's most complex subspecialties - backed by the full operational power of a global CRO.
Every Subspecialty Has Its Challenges. We Know Them All.
Full Spectrum of Ophthalmic Trial Types
We also offer expert contract auditing services for ophthalmology clinical trials.
Ophthalmic trials are unlike any others. Endpoints are visual, subjective, and sensitive. Patient populations are often elderly or pediatric. Regulatory requirements vary across markets. And enrollment - in a field where patients may have limited vision - requires exceptional site management and patient care.
Our teams understand all of this. Not from textbooks - from experience.
At CorNeat Vision, we knew that taking our human feasibility study outside the U.S. would be a massive undertaking. We didn't just need a CRO; we needed a partner who knew the local landscape as well as we know our own technology. Across Medical was that partner. From day one, they brought a level of operational rigor that gave us immediate peace of mind.
They didn't just flag problems; they solved them before they could impact our timeline. Working with their team felt less like managing a vendor and more like adding a dedicated wing to our internal staff. I can say with total confidence that our program advanced faster and smoother because Across Medical was in our corner.
BELKIN Vision collaborated with Across Medical on several projects, and the experience was consistently productive and efficient. The team was responsive, professional, and worked seamlessly on study, regulatory, site interactions and translations.
What sets aCROss apart is the physician-led approach. Having MDs who understand both the science and the operational reality made a real difference in our ophthalmology program across Georgia and Armenia.
Other Therapeutic Areas
Let's Talk About Your Study
Whether you're developing a novel biologic for retinal disease, a next-generation IOL, or a cell therapy for corneal regeneration - we'd love to hear about your program.
Discuss Your Study